Mather Group’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
FBT
Mather Group's ATRC Position: Q3 2026 in Review
Mather Group held its AtriCure (ATRC) position steady in Q3 2026 at 15 shares worth $843. The position accounts for ﹤0.01% of the portfolio, ranked #2164.
Mather Group first reported a position in ATRC in Q2 2023 and has held it in 10 quarters since. The position peaked at $159K in Q2 2023. 40 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.
- Mather Group held 15 shares of AtriCure worth $843 as of Q3 2026.
- Mather Group left its AtriCure share count unchanged in Q3 2026.
- AtriCure made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #2164 holding.
- Mather Group first reported a position in AtriCure in Q2 2023 and has held it in 10 quarters since.
- Mather Group's AtriCure position peaked at $159K in Q2 2023.
- 40 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.
Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.